Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws.
Treister
Nathaniel S
NS
Division of Oral Medicine and Dentistry, Brigham and Women's Hospital, Boston, Massachusetts, USA. ntreister@partners.org
Friedland
Bernard
B
Woo
Sook-Bin
SB
D000328:Adult; D000368:Aged; D019386:Alendronate / Q000009:adverse effects; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D054893:Cone-Beam Computed Tomography / Q000379:methods*; D004164:Diphosphonates / Q000009:adverse effects*; D004368:Dry Socket / Q000139:chemically induced / Q000000981:diagnostic imaging; D005260:Female; D006801:Humans; D021621:Imaging, Three-Dimensional / Q000379:methods; D007093:Imidazoles / Q000009:adverse effects; D008297:Male; D008336:Mandibular Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D008439:Maxillary Diseases / Q000139:chemically induced / Q000000981:diagnostic imaging; D008875:Middle Aged; D009957:Oroantral Fistula / Q000139:chemically induced / Q000000981:diagnostic imaging; D010020:Osteonecrosis / Q000139:chemically induced* / Q000000981:diagnostic imaging; D010026:Osteosclerosis / Q000139:chemically induced / Q000000981:diagnostic imaging; D000077268:Pamidronate; D019252:Radiography, Dental, Digital / Q000379:methods; D011862:Radiography, Panoramic / Q000379:methods; D020390:Tooth Socket / Q000000981:diagnostic imaging / Q000187:drug effects; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid; D000077268:Pamidronate; D019386:Alendronate